Relmada Therapeutics, Inc.
RLMD · NASDAQ
Bulios Fair Price
$3.36
25.7% downside
Trenutna cena
$4.52
Po podatkih Bulios Fair Price je delnica RLMD trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Relmada Therapeutics, Inc. (RLMD) is a biopharmaceutical company focused on the development and commercialization of drugs for the treatment of central nervous system disorders and other neurologically focused health conditions. Their research and development programs are aimed at discovering and developing new drug therapies for mood disorders, pain, and other neurological diseases. Among their main products are drugs based on new pharmacological mechanisms, which have the potential to provide new therapeutic options for patients with these health conditions. Relmada Therapeutics, Inc. aims to bring innovative treatment approaches and improve the quality of life for patients suffering from neurological disorders.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Sergio Traversa
Employees
17
Headquarters
Coral Gables
Prihajajoči dogodki
Earnings
Upcoming earnings report